Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 12 Feb 2022
Pfizer and BioNTech provide update on rolling submission for emergency use authorisation of their COVID-19 vaccine in children 6 months through 4 years of age
11 February 2022 - Pfizer and BioNTech today announced plans to extend their rolling submission to the U.S. FDA seeking ...
Posted by Michael Wonder on 11 Feb 2022
Health economic assessment of Adakveo for the treatment of sickle cell anaemia
11 February 2022 - Adakveo is used to prevent recurrent so-called vaso-occlusive crises in patients from 16 years of age who ...
Posted by Michael Wonder on 11 Feb 2022
Lilly's bebtelovimab receives emergency use authorisation for the treatment of mild to moderate COVID-19
11 February 2022 - Bebtelovimab neutralises Omicron as demonstrated by pseudovirus and authentic virus data ...
Posted by Michael Wonder on 11 Feb 2022
Agenda for the May 2022 PBAC intracycle meeting
11 February 2022 - The agenda for the May 2022 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 11 Feb 2022
The Government could force a price cut for this prostate cancer drug by as much as 80%. Why hasn’t it acted?
10 February 2022 - Xtandi, a wonder drug for prostate cancer, was developed at UCLA with substantial funding from the ...
Posted by Michael Wonder on 11 Feb 2022
AbbVie announces first provincial reimbursements for Venclexta (venetoclax) in combination with azacitidine for acute myeloid leukaemia patients
10 February 2022 - Following the signing of an agreement between AbbVie and the pan-Canadian Pharmaceutical Alliance, Quebec, Saskatchewan, and ...
Posted by Michael Wonder on 11 Feb 2022
New advice to keep Australians ‘up to date’ with COVID-19 vaccinations
10 February 2022 - The Australian Government has today received updated advice from the medical experts of the Australian Technical Advisory ...
Posted by Michael Wonder on 11 Feb 2022
U.S. FDA advisers call for new trial of Lilly, Innovent lung cancer drug
10 February 2022 - Innovent Biologics and Eli Lilly should be required to conduct a trial of their lung cancer ...
Posted by Michael Wonder on 10 Feb 2022
Patent box legislation to promote Australian innovation
11 February 2022 - Medicines Australia notes the introduction of patent box legislation, Treasury Laws Amendment (Tax Concession for Australian ...
Posted by Michael Wonder on 10 Feb 2022
SMC approves Biogen’s Vumerity for patients with multiple sclerosis
9 February 2022 - The new, at home oral treatment has been developed for adults in Scotland living with relapsing-remitting multiple ...
Posted by Michael Wonder on 10 Feb 2022
Biogen urges Medicare to reverse proposed limits on coverage of Alzheimer's drug
11 February 2022 - Biogen is urging Medicare to broadly reimburse its recently authorised Alzheimer's drug, in response to a ...
Posted by Michael Wonder on 10 Feb 2022
Theragnostics announces that its radiotherapeutic for treatment of glioblastoma multiforme has been awarded UK's MHRA innovation passport
10 February 2022 - Promising non-clinical results support Phase 1 clinical study in recurrent glioblastoma multiforme. ...
Posted by Michael Wonder on 10 Feb 2022
Eli Lilly promises 40% discount for Innovent’s PD-1 in last-ditch bid to shift FDA review to drug pricing
10 February 2022 - Eli Lilly has been talking up a “disruptive” pricing strategy for its Innovent Biologics partnered PD-1 ...
Posted by Michael Wonder on 10 Feb 2022
South Africa’s antitrust regulator wants Roche penalised for ‘excessive’ cancer drug pricing
9 February 2022 - South Africa’s anti-trust regulator has recommended that Roche should be penalised for allegedly “excessive” pricing of ...
Posted by Michael Wonder on 10 Feb 2022
Three doses to be ‘up to date’ as national cabinet prepares for winter waves
10 February 2022 - Top Australian health officials now say people need a third coronavirus vaccine dose to be considered up ...